SCHEMBL8747893

SCHEMBL8747893

CCN(CC)CCC(=O)OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
TSHR P16473 4/20 0.55
L3MBTL1 Q9Y468 1/20 0.47
KDM5A P29375 2/20 0.42
LMNA P02545 3/20 0.40
CA12 O43570 2/20 0.40
CA14 Q9ULX7 2/20 0.40
PAOX Q6QHF9 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
TERT O14746 3/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL28844140 0.98 KMT2A (0.56) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL15783059 0.96 KMT2A (0.54) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL13194984 0.95 KMT2A (0.58) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL15781687 0.91 KMT2A (0.54) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL15781754 0.91 KMT2A (0.54) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL12847857 0.89 KMT2A (0.52) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL18912868 0.88 KMT2A (0.47) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL64783 0.87 KMT2A (0.65) KMT2AMEN1TSHRL3MBTL1KDM5A
Hydrochloric Acid SCHEMBL8341262 0.87 TSHR (0.54) KMT2AMEN1TSHRL3MBTL1KDM5A
SCHEMBL15783047 0.87 KMT2A (0.46) KMT2AMEN1TSHRL3MBTL1KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114394898-A Preparation method of 5-oxohexanoate 山东智永化工产业技术研究院有限公司 2022-04-26 CN claimed
CN-111054445-B Method for preparing 3-diethylamino-N, N-diethyl propionamide through amidation, catalyst and application thereof 山东瑞博龙化工科技股份有限公司 2021-11-09 CN claimed
CN-111054445-A Method for preparing 3-diethylamino-N, N-diethyl propionamide through amidation, catalyst and application thereof 山东瑞博龙化工科技股份有限公司 2020-04-24 CN claimed
WO-2024165831-A1 IMIDAZOLIDONE AND SUCCINIMIDE DERIVATIVES FOR USE AS ALPHA V BETA 3 INTEGRIN INHIBITORS FOR THE TREATMENT OF CANCER UNIVERSITY OF BRADFORD (GB) 2024-08-15 WO disclosed
EP-4223285-A2 METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST Novartis AG (CH) 2023-08-09 EP disclosed
EP-3169309-B1 METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST NOVARTIS AG (CH) 2023-05-10 EP disclosed
EP-4019506-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS Novartis AG (CH) 2022-06-29 EP disclosed
CN-114394898-A Preparation method of 5-oxohexanoate 山东智永化工产业技术研究院有限公司 2022-04-26 CN disclosed
EP-3083579-B1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS AG (CH) 2022-01-26 EP disclosed
CN-111054445-B Method for preparing 3-diethylamino-N, N-diethyl propionamide through amidation, catalyst and application thereof 山东瑞博龙化工科技股份有限公司 2021-11-09 CN disclosed
CN-111054445-B Method for preparing 3-diethylamino-N, N-diethyl propionamide through amidation, catalyst and application thereof 山东瑞博龙化工科技股份有限公司 2021-11-09 CN disclosed
CN-106574166-A Surface coating material, coating film, and hydrophilic/oil-repellent material 三菱综合材料株式会社 2017-04-19 CN disclosed
US-20160139136-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2016-05-19 US disclosed
US-20160139136-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2016-05-19 US disclosed
WO-2016010840-A1 METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST NOVARTIS AG (CH) 2016-01-21 WO disclosed
WO-2015095346-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS AG (CH) 2015-06-25 WO disclosed
EP-0619295-B1 PROCESS FOR PRODUCING N-MONOSUBSTITUTED (METH)ACRYLAMYDE KOHJIN CO (JP) 1997-03-12 EP disclosed
US-5587515-A Method of manufacturing N-monosubstituted (meth)acrylamides KOHJIN CO., LTD. (JP) 1996-12-24 US disclosed
EP-0619295-A1 PROCESS FOR PRODUCING N-MONOSUBSTITUTED (METH)ACRYLAMYDE KOHJIN CO. Ltd. (JP) 1994-10-12 EP disclosed
US-4912216-A Method for production of perfluoro-(N-vinylamine) compounds AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1990-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160139136-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS FUT5, FUT6, CSGALNACT1 KMT2A 3081/4885MEN1 2746/4885TSHR 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.